{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:12:48Z","timestamp":1772806368288,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":876,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1999,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>: In patients with low\u2010grade reflux oesophagitis adequate symptom control is the aim of treatment. Effervescent tablets alleviate heartburn more rapidly than ordinary tablets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>: To investigate symptom control, patient satisfaction, health\u2010related quality of life and disease progress when ranitidine 150\u2003mg effervescent tablets were offered as on demand treatment. We also wanted to investigate whether any biological or psycho\u2010social factor could predict patient satisfaction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>: Consecutive patients with endoscopically verified reflux oesophagitis grade I\u2013II were followed up for 12\u2003months. 24\u2003h pH\u2010metry, disease history, symptoms and several psycho\u2010social factors were registered at baseline and 12\u2003months follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>: Eighty\u2010one patients were included. Mean age was 50.7\u2003years (range 21\u201382), 63% were men. Mean tablet consumption was 1.21 per day (range 7\u20131016 tablets\/year). At the 1\u2010year follow\u2010up discomfort resulting from reflux symptoms was significantly reduced (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001), and the patients\u2019 social and vocational life improved. Eighty\u2010four percentage of the patients were satisfied with the treatment. 24\u2003h pH\u2010metry or number of reflux episodes did not change. We did not find any factors able to predict patient satisfaction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>: On demand therapy with ranitidine effervescent tablets was well accepted by the majority of patients with reflux oesophagitis grade I. Even though the number of reflux episodes did not change, the patients experienced less discomfort due to reflux symptoms, and their social and vocational life was better. There was no significant progression of the disorder during the 1\u2010year follow\u2010up. No predictive factor for patient satisfaction was found.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1999.00575.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:38:56Z","timestamp":1047353936000},"page":"1035-1040","source":"Crossref","is-referenced-by-count":20,"title":["On demand therapy of reflux oesophagitis \u2014 a prospective study of symptoms, patient satisfaction and quality of life"],"prefix":"10.1111","volume":"13","author":[{"family":"Wilhelmsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hatlebakk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Olafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Berstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001574-199807000-00011"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.4.481"},{"key":"e_1_2_6_4_2","first-page":"101","article-title":"Pathogenesis of esophagitis in patients with gastroesophageal reflux","volume":"88","author":"Little AG","year":"1980","journal-title":"Surg"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199806000-00004"},{"key":"e_1_2_6_6_2","first-page":"70","article-title":"Rapid absorption and high plasma concentration with the ranitidine effervescent formulation results in very quick onset of action on the intragastric pH in volunteers","volume":"28","author":"Devis G","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00264.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528609034622"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096076"},{"key":"e_1_2_6_10_2","unstructured":"CastellDO&CastellJA eds. Esophageal Motility Testing 2nd edn. Norwalk: Appleton & Lange 1994:323."},{"key":"e_1_2_6_11_2","unstructured":"CastellJA.Esophageal manometry. In: Castell DO ed. The Esophagus 2nd edn. Boston: Little Brown 1995: 133\u201352."},{"key":"e_1_2_6_12_2","unstructured":"EysenckHJ. The structure of Human Personality. London: Mitchum 1953."},{"key":"e_1_2_6_13_2","unstructured":"GoldbergD&WilliamsP. A User\u2019s Guide to the General Health Questionnaire. Windsor: NFER\u2010Nelson 1988."},{"key":"e_1_2_6_14_2","unstructured":"DerogatisLR&LopezMC. PAIS PAIS\u2010SR. Administration Scoring and Procedures Manual. Baltimore: John Hopkins University School of Medicine 1983."},{"key":"e_1_2_6_15_2","unstructured":"BrahlerE&ScheerJ. Der Giessener Beschwerdebogen (GBB). Bern: Hans Huber 1983."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409092481"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00272.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510263331703"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091035"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-11-199606010-00002"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00575.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1999.00575.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1999.00575.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T13:52:55Z","timestamp":1698501175000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1999.00575.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["10.1046\/j.1365-2036.1999.00575.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1999.00575.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}